(Q34185330)

31 July 2017

1 reference

title

Serotonin in mania and in the mechanism of action of mood stabilizers: a review of clinical studies (English)

1 reference

31 July 2017

0 references

Shiah IS

1

1 reference

31 July 2017

Yatham LN

series ordinal

2

1 reference

31 July 2017

language of work or name

1 reference

1 June 2000

1 reference

31 July 2017

1 reference

31 July 2017

volume

2

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

77-92

1 reference

Classification and nomenclature of 5-HT receptors: a comment on current issues

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

5-HT receptor classification and nomenclature: towards a harmonization with the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

The molecular biology of serotonin receptors: therapeutic implications for the interface of mood and psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Anatomy of the serotonergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

L-tryptophan in mania. Contribution to a permissive hypothesis of affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Abnormalities of indoleamines in affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Biogenic Amine Metabolites in Cerebrospinal Fluid of Depressed and Manic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Neuronally activated metabolism of brain serotonin: Effect of lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Short- and long-term lithium administration: effects on the brain's serotonergic biosynthetic systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Lithium and serotonin function: implications for the serotonin hypothesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Effect of tryptophan administration on tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human lumbar and cisternal cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Correlations between aminergic metabolites simultaneously obtained from human CSF and brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Correlation between cerebrospinal fluid amine metabolites and psychomotor activity in affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in psychiatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

CSF monoamine metabolites in mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Depressive mania versus agitated depression: biogenic amine and hypothalamic-pituitary-adrenocortical function

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Concentrations of 5-hydroxyindolylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Concentrations of 5-Hydroxyindole-acetic Acid and Homovanillic Acid in the Cerebrospinal Fluid after Treatment with Probenecid in Patients with Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

5-Hydroxyindoleacetic Acid Levels in the Cerebrospinal Fluid of Depressive Patients treated with Probenecid

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Reduced Central Serotonergic Activity in Mania: Implications for the Relationship between Depression and Mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

The human platelet. A diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Studies on human blood platelets in affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Changes in platelet 5-hydroxytryptamine uptake in mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Platelet tritiated imipramine binding in patients suffering from mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

The calcium second messenger system in bipolar disorders: data supporting new research directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

A study of platelet serotonin receptor in mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Neuroendocrine probes of serotonergic function: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Neuroendocrine markers of serotonin responsivity in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Evaluation of central serotonergic function in affective and related disorders by the fenfluramine challenge test: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Prolactin and cortisol responses to fenfluramine challenge in mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

d-fenfluramine-induced prolactin responses in mania: evidence for serotonergic subsensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Hormonal probes of central serotonergic activity: do they really exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5-hydroxytryptaminergic neurones. Studies with fenfluramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. I. Enhanced response in depression and mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Stimulation of corticosterone and beta-endorphin secretion in the rat by selective 5-HT receptor subtype activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

5-HT neuroendocrine responses during psychotropic drug treatment: an investigation of the effects of lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Long-term effect of lithium on the uptake of 5-hydroxytryptamine by human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

3H-imipramine binding sites in platelets from psychiatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. III. Effect of antidepressants and lithium carbonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Lithium treatment and serotoninergic function. Neuroendocrine and behavioral responses to intravenous tryptophan in affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Lithium increases 5-HT-mediated neuroendocrine responses in tricyclic resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Lithium in Tricyclic-Resistant Depression Correlation of Increased Brain 5-HT Function with Clinical Outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Effect of clomipramine and lithium on fenfluramine-induced hormone release in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Lithium increases 5-HT-mediated prolactin release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

The mechanisms of action of lithium. I. Effects on serotoninergic and noradrenergic systems in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Effect of lithium on the prolactin response to D-fenfluramine in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Effect of the oral administration of tryptophan-free amino acid mixtures on serum tryptophan, brain tryptophan and serotonin metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Tryptophan depletion causes a rapid lowering of mood in normal males

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Biochemical aspects of tryptophan depletion in primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Tryptophan depletion during continuous CSF sampling in healthy human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Differences between males and females in rates of serotonin synthesis in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Rapid depletion of plasma tryptophan: a review of studies and experimental methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Beyond lithium in the treatment of bipolar illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Effects of subchronic treatment with valproate on L-5-HTP-induced cortisol responses in mania: evidence for increased central serotonergic neurotransmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

The pharmacology of the hypothermic response in mice to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). A model of presynaptic 5-HT1 function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Characterization of 8-OH-DPAT-induced hypothermia in mice as a 5-HT1A autoreceptor response and its evaluation as a model to selectively identify antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Effects of carbamazepine on dopamine- and serotonin-mediated neuroendocrine responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Anticonvulsant drugs alter plasma tryptophan concentrations in epileptic patients: implications for antiepileptic action and mental function

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

5-HT brain function in affective disorder: d,l-fenfluramine-induced hormone release and clinical outcome in long-term lithium/carbamazepine prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Clinical studies on the use of lamotrigine in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Lamotrigine: an antiepileptic agent for the treatment of partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Effects of lamotrigine on the 5-HT1A receptor function in healthy human males

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

An open label study of gabapentin in the treatment of acute mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

A summary of mechanistic hypotheses of gabapentin pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Selected CSF biochemistry and gabapentin concentrations in the CSF and plasma in patients with partial seizures after a single oral dose of gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Use of topiramate, a new anti-epileptic as a mood stabilizer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Topiramate: a review of preclinical, pharmacokinetic, and clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

A pharmacological and clinical review on topiramate, a new antiepileptic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Serotonin 5-HT2 receptors in schizophrenia: a PET study using [18F]setoperone in neuroleptic-naive patients and normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Loss of brain 5-HT2 receptors in Alzheimer's disease. In vivo assessment with positron emission tomography and [18F]setoperone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Frontal 5-HT2A receptors studied in depressive patients during chronic treatment by selective serotonin reuptake inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labeled setoperone

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

GABA function in mood disorders: an update and critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

The platelet intracellular calcium response to serotonin is augmented in bipolar manic and depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

Humoral changes in manic-depressive psychosis with particular reference to the excretion of catechol amines in urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Cerebrospinal fluid 5-hydroxyindoleacetic acid as an index of central serotonergic processes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Cerebrospinal Fluid Levels of MHPG in Affective Disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

5-Hydroxyindolacetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

5-Hydroxyindole acetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis and the effect of probenecid treatment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Serotonin uptake in blood platelets of psychiatric patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Decreased platelet serotonin uptake in bipolar I patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Tritiated imipramine binding to platelets in manic subjects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Platelet 3H-imipramine binding in bipolar patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Serotoninergic Dysfunction in Bipolar Disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Effect of various factors on serotonin-induced Ca2+ response in human platelets

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Serotonin-induced platelet calcium mobilization is enhanced in mania

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Buspirone induced prolactin release in mania

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Endocrine responses to 5-hydroxytryptamine-1A receptor activation by ipsapirone in humans

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Hypothermic, ACTH, and cortisol responses to ipsapirone in patients with mania and healthy controls

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Hypothalamic paraventricular nucleus lesions differentially affect serotonin-1A (5-HT1A) and 5-HT2 receptor agonist-induced oxytocin, prolactin, and corticosterone responses

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Sumatriptan-Induced Growth Hormone Release in Patients with Major Depression, Mania, and Normal Controls

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

A review of the biochemical and neuropharmacological actions of lithium

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Relationship between depression and mania

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

The effect of lithium treatment on manic symptoms and levels of monoamine metabolites in cerebrospinal fluid of manic depressive patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Cerebrospinal fluid and plasma monoamines and their metabolites in euthymic bipolar patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Lithium carbonate treatment of mania. Cerebrospinal fluid and urinary monoamine metabolites and treatment outcome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Effect of lithium carbonate on serotonin uptake in blood platelets of patients with affective disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Short-term lithium administration to healthy volunteers produces long-lasting pronounced changes in platelet serotonin uptake but not imipramine binding

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Stimulation by lithium of monoamine uptake in human platelets

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Lithium restores abnormal platelet 5-HT transport in patients with affective disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Platelet [3H]imipramine binding in affective disorders: trait versus state characteristics

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Platelet 3H-imipramine binding in euthymic bipolar patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Apparent supersensitivity of platelet 5-HT receptors in lithium-treated patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Increased plasma free serotonin but unchanged platelet serotonin in bipolar patients treated chronically with lithium

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Serotonergic function during lithium augmentation of refractory depression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Lithium and 5-HT1A receptor sensitivity: a neuroendocrine study in healthy volunteers

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

The influence of fenfluramine stimulation on prolactin plasma levels in lithium long-term-treated manic-depressive patients and healthy subjects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Fenfluramine stimulation of serum cortisol in patients with major affective disorders and healthy controls: further evidence for a central serotonergic action of lithium in man

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Dose-response decrease in plasma tryptophan and in brain tryptophan and serotonin after tryptophan-free amino acid mixtures in rats

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Tryptophan depletion in stable lithium-treated patients with bipolar disorder in remission

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Effects of acute tryptophan depletion in lithium-remitted manic patients: a pilot study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Tryptophan depletion in recently manic patients treated with lithium

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Effects of Divalproex Sodium on 5-HT1A Receptor Function in Healthy Human Males: Hypothermic, Hormonal, and Behavioral Responses to Ipsapirone

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Role of precursor availability in control of monoamine biosynthesis in brain

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

1 reference

7 January 2021

Acute treatment of bipolar depression with gabapentin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Gabapentin in the treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

Gabapentin augments whole blood serotonin in healthy young men

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

PET imaging of cortical S2 serotonin receptors after stroke: lateralized changes and relationship to depression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020201.X

7 January 2021

10.1034/J.1399-5618.2000.020201.X

Identifiers

DOI

1 reference

31 July 2017

1 reference